IMPROVING DRUG UPTAKE AND PENETRATION INTO TUMORS: CURRENT AND FORTHCOMING OPPORTUNITIES.

IMPROVING DRUG UPTAKE AND PENETRATION INTO TUMORS: CURRENT AND FORTHCOMING OPPORTUNITIES.

Bibliographic Details
Main Authors:	Fabrizio eMarcucci, Ronald eBerenson, Angelo eCorti
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2013-06-01
Series:	Frontiers in Oncology
Subjects:	Antibodies chemotherapy tumor immune cells Promoter Drug Effector Drug
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fonc.2013.00161/full

Similar Items

INFLUENCE OF THE DURATION OF INTRAVENOUS DRUG ADMINISTRATION ON TUMOR UPTAKE
by: Sylvain eFouliard, et al.
Published: (2013-07-01)

Anti-Cancer Stem-like Cell Compounds in Clinical Development – An Overview and Critical Appraisal.
by: Fabrizio eMarcucci, et al.
Published: (2016-05-01)

Antibody-Drug Conjugates (ADC) Against Cancer Stem-Like Cells (CSC)—Is There Still Room for Optimism?
by: Fabrizio Marcucci, et al.
Published: (2019-03-01)

Glycolysis-induced drug resistance in tumors—A response to danger signals?
by: Fabrizio Marcucci, et al.
Published: (2021-02-01)

Breaching the Blood–Brain Tumor Barrier for Tumor Therapy
by: Fabrizio Marcucci, et al.
Published: (2021-05-01)

Antibody structure and engineering considerations for the design and function of Antibody Drug Conjugates (ADCs)
by: Ricarda M. Hoffmann, et al.
Published: (2018-03-01)

SINGLE DOMAIN ANTIBODIES AND BIOENGINEERING DRUGS ON THEIR BASIS: NEW OPPORTUNITIES FOR DIAGNOSTICS AND THERAPY
by: E. N. Gorshkova, et al.
Published: (2016-12-01)

Strategies to enhance monoclonal antibody uptake and distribution in solid tumors
by: Brandon M. Bordeau, et al.
Published: (2021-08-01)

Critical review of drug promotional literature using the World Health Organization guidelines
by: Puttaswamy Ganashree, et al.
Published: (2016-01-01)

P-glycoprotein Mediated Efflux Limits Substrate and Drug Uptake in a Preclinical Brain Metastases of Breast Cancer Model
by: Chris E Adkins, et al.
Published: (2013-11-01)

Drug Combination in Cancer Treatment—From Cocktails to Conjugated Combinations
by: Yosi Gilad, et al.
Published: (2021-02-01)

Repurposing chlorpromazine in the treatment of glioblastoma multiforme: analysis of literature and forthcoming steps
by: Claudia Abbruzzese, et al.
Published: (2020-01-01)

A mathematical model of doxorubicin penetration through multicellular layers,
by: Evans, C.J., et al.
Published: (2010)

The effects of sustained gepirone administration on rodent brain 5-HT receptors and behavioral analogues of anxiety
by: Benjamin, Daniel E. (Daniel Ernest)
Published: (1991)

A Sample-Sparing Multiplexed ADCP Assay
by: Audrey L. Butler, et al.
Published: (2019-08-01)

Critical evaluation of the validity of drug promotion materials in Ethiopia
by: Hailu HG, et al.
Published: (2019-07-01)

Photosensitive Supramolecular Micelle-Mediated Cellular Uptake of Anticancer Drugs Enhances the Efficiency of Chemotherapy
by: Yihalem Abebe Alemayehu, et al.
Published: (2020-06-01)

Application of monoclonal anti-CD20 antibody rituximab in the treatment of non-Hodgkin's lymphoma
by: Mihaljević Biljana, et al.
Published: (2008-01-01)

STUDY DATA OF KRAS- AND RAS-UNMUTATED (WILD) TYPE OF COLORECTAL CANCER
by: V. A. Gorbunova
Published: (2015-05-01)

High-Affinity Human Anti-c-Met IgG Conjugated to Oxaliplatin as Targeted Chemotherapy for Hepatocellular Carcinoma
by: Yilan Ma, et al.
Published: (2019-08-01)

Antibody–drug conjugates: Smart chemotherapy delivery across tumor histologies
by: Bardia, A., et al.
Published: (2022)

Editorial: Antibody Fc Engineering: Towards Better Therapeutics
by: Cheng Lei, et al.
Published: (2018-10-01)

Amplification of drug resistance against the background of inadequate chemotherapy for pulmonary tuberculosis
by: I. A. Burmistrova, et al.
Published: (2019-09-01)

Estimated need for anthelminthic medicines to control soil-transmitted helminthiases in school-aged children, 2020–2030
by: Chiara Marocco, et al.
Published: (2020-05-01)

Case Report: Oral Cimetidine Administration Causes Drug-Induced Immune Hemolytic Anemia by Eliciting the Production of Cimetidine-Dependent Antibodies and Drug-Independent Non-specific Antibodies
by: Yuanjun Wu, et al.
Published: (2021-09-01)

Current advances in mathematical modeling of anti-cancer drug penetration into tumor tissues
by: MunJu eKim, et al.
Published: (2013-11-01)

Antiviral Functions of Monoclonal Antibodies against Chikungunya Virus
by: Jing Jin, et al.
Published: (2019-03-01)

Requirement of Fc-Fc Gamma Receptor Interaction for Antibody-Based Protection against Emerging Virus Infections
by: Shamus P. Keeler, et al.
Published: (2021-05-01)

Use of a charge reducing agent to enable intact mass analysis of cysteine-linked antibody-drug-conjugates by native mass spectrometry
by: Kamila J. Pacholarz, et al.
Published: (2016-06-01)

Targeted drug delivery for cancer therapy: the other side of antibodies
by: Firer Michael A, et al.
Published: (2012-11-01)

Nanocarrier-mediated targeting of tumor and tumor vascular cells improves uptake and penetration of drugs into neuroblastoma
by: Fabio ePastorino, et al.
Published: (2013-08-01)

Synthesis of the anthraquinone portion of dynemicin A : Taxanes chiral construction of the A, B and C rings of taxol
by: Magnus, Nicholas Andrew
Published: (1996)

Genotoxic effects in cancer patients after treatment with single drug etoposide or melphalan chemotherapy
by: Karnaoukhova, Larissa
Published: (2017)

Biotherapeutics: Challenges and Opportunities for Predictive Toxicology of Monoclonal Antibodies
by: Dale E. Johnson
Published: (2018-11-01)

A current state of mycobacterioses
by: Zimina V.N., et al.
Published: (2017-11-01)

Challenges in Optimising the Successful Construction of Antibody Drug Conjugates in Cancer Therapy
by: Thomas Mehrling, et al.
Published: (2018-02-01)

<em>Shigella</em> pathogenesis: molecular and computational insights
by: Sarmishta Mukhopadhyay, et al.
Published: (2020-07-01)

Antibody–Drug Conjugates for the Treatment of Breast Cancer
by: Chiara Corti, et al.
Published: (2021-06-01)

Exploiting RAS Nucleotide Cycling as a Strategy for Drugging RAS-Driven Cancers
by: Tyler E. Mattox, et al.
Published: (2019-12-01)

Beyond Allotypes: The Influence of Allelic Diversity in Antibody Constant Domains
by: Annmaree K. Warrender, et al.
Published: (2020-08-01)

Cannot write session to /tmp/vufind_sessions/sess_7rn0778s4asspp8b2imnnqeg63